Gyder Surgical announces first commercial surgical cases in the United States performed by Dr. Paul M. Lombardi, M.D., at the Tri-County Orthopedics Joint Replacement Institute outpatient center
PALO ALTO, Calif. and MULGRAVE, Australia, Feb. 22, 2026 (GLOBE NEWSWIRE) --…
Dassault Systmes CEO Pascal Daloz becomes also Chairman of the Board of Directors of Dassault Systmes
Press ReleaseVELIZY-VILLACOUBLAY, France — February 21, 2026 Dassault Systèmes’ CEO Pascal Daloz…
Weaviate Launches Agent Skills to Empower AI Coding Agents
Amsterdam, Netherlands, Feb. 21, 2026 (GLOBE NEWSWIRE) -- February 20, 2026 –…
Seedance2ai.online Launches All-in-One Seedance 2.0 Video Creation Platform With Free Tier for Global Creators
LOS ANGELES, CA, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Seedance2ai.online today announced…
Amdavad 2030 Opens Doors to Global Business Opportunities
West Midlands Mayor Leads Strategic UK Delegation to Translate Sporting Ambition into…
Thermobalancing therapy emerges as drug-free option for BPH, chronic prostatitis, back pain and kidney stones
Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices…
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
February 20, 2026 15:10 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults
Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the…
LATHAM & WATKINS ELECTS 22 NEW PARTNERS
Promotions from counsel include skilled practitioners advising clients across transactional, litigation, and…
VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025
February 20, 2026 19:11 ET | Source: VERSES AI Inc. VANCOUVER, British…
